Home
Up
Contacts
Blood Disorders
Transplantation
Blood Products
Bone
                    Marrow
Links
PVT


Perth Haematology :: Dr Steven Ward

PBS Restrictions   -  January 2015


Myeloma
NHL
Thalidomide PBS S100 Arrangements
Rituximab (MabThera) PBS Authority Criteria
Lenalidomide (Revlimid): PBS S100 Arrangements
Brentiximab for CD30+ Anaplastic Large Cell Lymphoma
      PBS Initial Rx Application Form

       PBS Ongoing Rx: Phone: 1800 700 270 (Mon-Fri,  08am - 5pm, AEST)
CML / Ph+ ALL

    


First Line Rx Chronic Phase CML Imatinib / Dasatinib / Nilotinib
Pomalidomide (Pomalyst): PBS S100 Arrangements

Second/Third Line Rx (progression)  Dasatinib / Nilotinib
   

Imatinib for initial Rx accelerated / blast
Bortezomib (Velcade) : PBS S100 Arrangements
Imatinib (Glivec) S85 Arrangements (CML in all phases, Ph+ALL)
     PBS Initial Rx Application Form        Use for Re-treatment also

Dasatinib (Sprycel) S85 Arrangements (CML in all phases, Ph+ ALL) 
    PBS Continuing Therapy Application Form
Nilotinib (Tasigna) S85 Arrangements (CML in chronic, accelerated phases only)
G-CSF
Ponatinib (CML, ALL)
G-CSF S100 Restrictions and Codes



Iron Overload
MDS / AML
Deferasirox (Exjade) S100
Azacitidine (S100)

Lenalidomide for 5q- (S100)
ITP


Romiplostim (S100)
CLL

Eltrombopag (S100)
Obinutuzumab






Address for Written Applications:                                                                                         Celgene i-Access registration site

Medicare Australia

Prior Written Approvals Specialised Drugs

REPLY PAID 9826

HOBART TAS 7001

Telephone for Specialised Drugs: 1800 700 270   (Mon-Fri,  8am - 5pm, AEST)

Telephone for Authority Drugs: 1800 888 333